Wealth Trust Axiom LLC Aveo Pharmaceuticals, Inc. Transaction History

Wealth Trust Axiom LLC

  • $329 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

Apr 14, 2021
SELL
$5.97 - $15.28 $133,411 - $341,462
-22,347 Closed
0 $0
Q3 2020

Oct 21, 2020
BUY
$4.16 - $6.26 $95 - $143
23 Added 0.1%
22,347 $132,000
Q2 2020

Jul 31, 2020
BUY
$3.47 - $9.99 $58 - $169
17 Added 0.08%
22,324 $114,000
Q1 2020

Apr 10, 2020
BUY
$2.6 - $6.9 $57,998 - $153,918
22,307 New
22,307 $80,000

Others Institutions Holding AVEO

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About AVEO PHARMACEUTICALS, INC.

AVEO Quotes by TradingView
  • Ticker AVEO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 34,676,000
  • Description
  • AVEO Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing and commercializing medicines for cancer patients. It markets its lead candidate, FOTIVDA, an oral, once-daily, vascular endothelial growth factor receptor tyrosine kinase inhibitor, which is used for the treatment of renal cell carcinoma (RCC); and tivozanib for the ...
More about AVEO
Track This Portfolio

Track Wealth Trust Axiom LLC Portfolio

Follow Wealth Trust Axiom LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wealth Trust Axiom LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wealth Trust Axiom LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email